Recruiting Hemophilia Studies in San Francisco
About Hemophilia Clinical Trials in San Francisco
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 2 hemophilia clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 303 participants. Research is being sponsored by Pfizer, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in San Francisco — FAQ
Are there hemophilia clinical trials in San Francisco?
Yes, there are 2 hemophilia clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Francisco?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.
Are clinical trials in San Francisco free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 2 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated July 13, 2026 from ClinicalTrials.gov